Kevin McGann
Vice President of Finance
Professional Overview
Kevin McGann is an accomplished finance executive with extensive experience in the biopharmaceutical industry. As the Vice President of Finance at Accent Therapeutics, Inc., he oversees all financial operations and plays a strategic role in driving the company's growth and expansion.
Experience Summary
Current Role
As Vice President of Finance at Accent Therapeutics, Inc., Kevin is responsible for leading the company's financial strategy, planning, and reporting. He manages a team of financial professionals and collaborates closely with cross-functional leadership to ensure the company's financial goals and objectives are met. Under his guidance, Accent Therapeutics has achieved significant milestones, including securing $75 million in Series B funding and expanding its pipeline of innovative cancer therapeutics.
Career Progression
Prior to his current role, Kevin held progressive leadership positions within Accent Therapeutics, serving as Senior Director and Director of Finance. He played a pivotal role in streamlining financial processes, implementing robust financial controls, and supporting the company's successful transition from a clinical-stage to a commercial-stage organization.
Before joining Accent Therapeutics, Kevin gained valuable experience in the financial services industry. He served as a Senior Manager in the Technical Accounting group at Thermo Fisher Scientific, where he provided expert guidance on complex accounting and reporting matters. Earlier in his career, he spent several years at Deloitte & Touche, progressing from an Audit & Assurance Assistant to an Audit & Assurance Manager, honing his skills in financial auditing and business consulting.
Academic Background
Kevin holds a Bachelor of Science in Accountancy from Boston College. During his time at Boston College, he was a Teaching Assistant and Peer Mentor in the Portico Program, demonstrating his strong leadership and mentorship abilities.
Areas of Expertise
- Financial planning and analysis
- Strategic financial management
- Budgeting and forecasting
- Financial reporting and compliance
- Technical accounting and auditing
- Business process optimization
- Cross-functional collaboration and leadership
Professional Impact
Throughout his career, Kevin has made significant contributions to the organizations he has served. At Accent Therapeutics, he has played a crucial role in securing critical funding, optimizing financial processes, and aligning the company's financial strategy with its long-term objectives. His expertise in technical accounting and financial reporting has been instrumental in ensuring the company's financial integrity and transparency.
Conclusion
With his extensive finance expertise, strategic mindset, and proven track record of success, Kevin McGann is poised to continue driving Accent Therapeutics' financial growth and positioning the company for long-term success in the dynamic biopharmaceutical industry.
